Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104099063 | 10409906 | 3 | F | 20160727 | 20140826 | 20160804 | PER | US-PFIZER INC-2014236966 | PFIZER | 52.00 | YR | F | Y | 0.00000 | 20160804 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104099063 | 10409906 | 1 | PS | CHANTIX | VARENICLINE TARTRATE | 1 | UNK | U | 21928 | FILM-COATED TABLET | |||||||||
| 104099063 | 10409906 | 2 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | UNK | U | 20702 | ||||||||||
| 104099063 | 10409906 | 3 | SS | NEURONTIN | GABAPENTIN | 1 | UNK | U | 20235 | ||||||||||
| 104099063 | 10409906 | 4 | SS | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | UNK | U | 0 | ||||||||||
| 104099063 | 10409906 | 5 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | U | 0 | ||||||||||
| 104099063 | 10409906 | 6 | SS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104099063 | 10409906 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |